The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Murine B7-H3 Is a Negative Regulator of T Cells
Open accessAbstract
T cell activation is regulated by the innate immune system through positive and negative costimulatory molecules. B7-H3 is a novel B7-like molecule with a putative receptor on activated T cells. Human B7-H3 was first described as a positive costimulator, most potently inducing IFN-gamma production and cellular immunity. In this study we examined the expression and function of mouse B7-H3. B7-H3 is mostly expressed on professional APCs; its expression on dendritic cells appears to be up-regulated by LPS. In contrast to human B7-H3, we found that mouse B7-H3 protein inhibited T cell activation and effector cytokine production. An antagonistic mAb to B7-H3 enhanced T cell proliferation in vitro and led to exacerbated experimental autoimmune encephalomyelitis in vivo. Therefore, mouse B7-H3 serves as a negative regulator of T cell activation and function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, CD276 (B7-H3), known to augment Tregs and inhibit T cell responses (Costa et al., 2018, Prasad et al., 2004, Suh et al., 2003), was expressed most prominently on CAFs and TSKs.”
From Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma (2020) · cites this paper as Prasad et al., 2004
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1027 · Cited by 5,294
Nishimura, H., Nose, M., Hiai, H., Minato, N., & Honjo, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80089-8 · Cited by 2,749
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717
Dong, H., Zhu, G., Tamada, K., & Chen, L. (1999) · Nature Medicine · doi:10.1038/70932 · Cited by 2,496
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., et al. (2001) · Science · doi:10.1126/science.291.5502.319 · Cited by 1,868
Sharpe, A. H., & Freeman, G. J. (2002) · Nature reviews. Immunology · doi:10.1038/nri727 · Cited by 1,759
ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28
Hutloff, A., Dittrich, A. M., Beier, K. C., Eljaschewitsch, B., Kraft, R., Anagnostopoulos, I., & Kroczek, R. A. (1999) · Nature · doi:10.1038/16717 · Cited by 1,482
Antigen Recognition By Class-I Restricted T Lymphocyte
Townsend, A., & Bodmer, H. C. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.003125 · Cited by 1,193
Linsley, P. S., Brady, W., Grosmaire, L. S., Aruffo, A. A., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.173.3.721 · Cited by 1,126
Flagged first, then by citations
1 of the 42 references couldn’t be matched to a known paper.
Research works printed but not linked: 41
- 1985, Annu. Rev. Immunol., 237
- 1989, Annu. Rev. Immunol., 601
- 2002, Annu. Rev. Immunol., 197
- 1997, Crit. Rev. Immunol., 89
- 1991, J. Exp. Med., 721
- 1996, Annu. Rev. Immunol., 233
- 1999, Curr. Opin. Cell Biol., 203
- 1997, Immunity, 445
- 1999, Nature, 263
- 1999, Nature, 827
- 1999, Immunity, 423
- 2003, J. Autoimmun., 255
- 2001, Nature, 97
- 2001, J. Immunol., 3659
- 2001, Nature, 102
- 2001, Nature, 105
- 2003, Immunity, 801
- 1999, Immunity, 141
- 2000, J. Exp. Med., 1027
- 2001, Science, 319
- 2003, Immunity, 863
- 2003, Immunity, 849
- 2003, Proc. Natl. Acad. Sci. USA, 10388
- 2003, Nat. Immunol., 670
- 2001, Nat. Immunol., 269
- 2002, J. Immunol., 6294
- 2002, J. Immunol., 3847
- 1995, Curr. Opin. Immunol., 333
- 1999, J. Exp. Med., 309
- 2000, Nature, 91
- 2002, J. Exp. Med., 97
- 2001, Proc. Natl. Acad. Sci. USA, 13866
- 1998, Science, 2263
- 2002, Annu. Rev. Immunol., 29
- 2003, Nat. Immunol., 899
- 2002, J. Immunol., 4524
- 2003, Genomics, 365
- 2003, Gene Ther., 1728
- 2002, J. Clin. Invest., 295
- 1999, Nat. Med., 1365
- 2002, Nat. Rev. Immunol., 116
Cited by
Sorted by citations
Items 301–368 of 368
Haberecker, M., Rüschoff, J. H., Andriakopoulou, C., Gray, S. G., Nackaerts, K., de Perrot, M. E., Brčić, L., Nadal, E., Tsimpoukis, S., Ampollini, L., et al. (2025) · JCO Precision Oncology · doi:10.1200/po-24-00675 · Cited by 3
Ding, S., Shan, Y., Sun, L., Li, S., Jiang, R., Chang, X., Huang, Z., Sun, J., Liu, C., Fang, C., et al. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00592-7 · Cited by 3
Soluble forms of immune checkpoints in ovarian cancer
Kovaleva, O. V., Belova, T. P., Kushlinsky, D. N., Korotkova, E. A., Алексеевна, П. П., Gratchev, A. N., Zinoviev, S. V., Терешкина, И. В., Sokolov, N. Y., Kudlay, D. A., et al. (2021) · Russian Clinical Laboratory Diagnostics · doi:10.51620/0869-2084-2021-66-2-80-86 · Cited by 3
Zhou, J., Blevins, L. K., Crawford, R. B., & Kaminski, N. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.884203 · Cited by 3
“One example is B7-H3 which has recently been described in promoting immune suppression in the tumor microenvironment (79, 80).”
Background(2005) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.15.6.745 · Cited by 3
“Although two studies in mice [10,14] have corroborated the findings obtained here with human T cells in vitro, other studies have lent support to the opposite conclusion that B7-H3 acts to augment T cell activation.”
BackgroundResultFramework of Intrinsic Immune Landscape of Dormant Prostate Cancer
Wong, N. K. Y., Dong, X., Lin, Y., Xue, H., Wu, R., Lin, D., Collins, C. C., & Wang, Y. Z. (2022) · Cells · doi:10.3390/cells11091550 · Cited by 3
“B7-H3 can exert its inhibitory influence on Th1 response [64], T cell effector function [65], and NK cytolytic activity [66], potentially promoting immune evasion.”
BackgroundEquine Arteritis Virus in Monocytic Cells Suppresses Differentiation and Function of Dendritic Cells
Moyo, N. A., Westcott, D., Simmonds, R. E., & Steinbach, F. (2023) · Viruses · doi:10.3390/v15010255 · Cited by 3
“B7-H3 is now assumed to have a predominantly inhibitory role, suppressing T-cell activation and B7-H3 on DC reduces CD4+ and CD8+ T-cell activation, as well as effector cytokine release by inhibiting the expression of major transcriptional factors, such as NF-κB, while expression in tumour cells has been shown to supp…”
BackgroundGuo, X., Yu, S., Ren, X., & Li, L. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e19222 · Cited by 3
Models of Immune Function in Aging
Jolly, C. A., & Xu, Z. (2006) · Elsevier eBooks · doi:10.1016/b978-012369391-4/50066-7 · Cited by 3
Zhang, Q., Fu, C., Liu, S., Leng, Y., Duan, L., Wang, N., Zhang, L., & Qiao, H. (2025) · PLoS ONE · doi:10.1371/journal.pone.0330722 · Cited by 3
Prognostic Role of B7-H3 (CD276) Expression in Initial Biopsies of Metastatic Prostate Cancer
Yusuf, A., & Pramanik, P. (2025) · Onco · doi:10.3390/onco5030038 · Cited by 3
Zhang, Q., Chiang, Z.-C., Weng, H., Chen, X., Zhao, N., Yan, C., Xiao, Y., Lin, J., & Xu, Y. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117673 · Cited by 3
Prognostic and therapeutic roles of B7-H3 and B7-H4 in prostate cancer
Hu, Y., Yang, W., Guo, S., & Huang, D. (2026) · Discover Oncology · doi:10.1007/s12672-026-04926-0 · Cited by 2
“Combination therapeutic strategies, such as radiotherapy and androgen-receptor pathway inhibitors (ARPI), are shown as potential complementary approaches to B7-H3-targeted treatments production (e.g., IFN-γ, IL-2), and cytolytic activity [11, 12, 28].”
Fard, A. K. L., Haake, A. F. H., Jovanovic, V. M., Andreotti, S., Hummel, M., Hempel, B.-F., & Gruber, A. D. (2024) · PeerJ · doi:10.7717/peerj.18444 · Cited by 2
“B7-H3 and B7-H4 on APCs mainly possess inhibitory functions, suppressing T cell activation and proliferation via still unknown receptors ( Hofmeyer, Ray & Zang, 2008 ; Prasad et al., 2004 ; Sica et al., 2003 ; Zang et al., 2007 ).”
Soluble B7 and TNF family in colorectal cancer: Serum level, prognostic and treatment value
Monfared, M. S., Nazmi, S., Parhizkar, F., & Jafari, D. (2025) · Human Immunology · doi:10.1016/j.humimm.2025.111232 · Cited by 2
Sakthivel, P., Wang, X., Gharizadeh, B., Giscombe, R., Pirskanen, R., Nyrén, P., & Lefvert, A. K. (2006) · Journal of Genetics · doi:10.1007/bf02935335 · Cited by 2
A Tapestry of Immunotherapeutic Fusion Proteins: From Signal Conversion to Auto-stimulation
Tykocinski, M. L., Huang, J.-H., Weber, M. C., & Dranitzki-Elhalel, M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-569-5_39 · Cited by 1
Next generation immune checkpoints
Perez, N. M., Moziak, K., & Martin, A. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.90009-2 · Cited by 1
Zhai, C., Ye, J., Li, X., Liu, J., Zhou, X., Wang, Z., Zhang, X., Zeng, W., Luo, H., Chen, L., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1751400 · Cited by 1
“Studies by Prasad et al. fi rst demonstrated that B7-H3 expressed on dendritic cells preferentially down-regulates Th1-mediated immune responses (26), while Castriconi et al. showed that 4Ig-B7-H3 serves as a tumor-associated antigen that protects neuroblastoma cells from NK cell-mediated lysis (27).”
New potential checkpoint inhibitors in cancer therapy
Kopecký, J. (2022) · Onkologie · doi:10.36290/xon.2022.022 · Cited by 1
Targeting the Immune Checkpoint in Bladder Cancer
Mercinelli, C., Tateo, V., Crupi, E., Cigliola, A., & Necchi, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-68505-7_23 · Cited by 1
Potential value of B7-H3 in sepsis diagnosis and prognosis: A Mendelian randomization study.
Guo, M., & He, Z. (2024) · PubMed Central · doi:10.11817/j.issn.1672-7347.2024.240139 · Cited by 1
Promising Immunotherapeutic Approaches in Clinical Trials
Rotte, A., & Bhandaru, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-48066-4_15 · Cited by 1
Du, H., Hirabayashi, K., Ahn, S., Kren, N. P., Montgomery, S. A., Wang, X., Tiruthani, K., Mirlekar, R., Michaud, D. E., Greene, K. G., et al. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3280238 · Cited by 1
Glazer, S. E., Sutton, M. N., Yang, P., Pisaneschi, F., Sebastian, M. M., Gammon, S. T., & Piwnica-Worms, D. R. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.20.629740 · Cited by 1
Co-stimulation Regulation of Immune Tolerance and Autoimmunity
Dong, C., Nurieva, R., & Martín‐Orozco, N. (2007) · Springer eBooks · doi:10.1007/978-0-387-36003-4_7 · Cited by 1
Modulation of dendritic cells and autoimmunity by apoptotic and necrotic cells
Miller, J. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Immunogenicity of pluripotent stem cells and their differentiation products
Monecke, S. (2013) · doi:10.53846/goediss-3881 · Cited by 1
Chauvin, C. (2007) · OpenGrey (Institut de l'Information Scientifique et Technique)
Inman, B. A., Frigola, X., Dong, H., Yang, J. C., & Kwon, E. D. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-332-5_21
Regulation of transplantation tolerance by antigen-presenting cells
Gorczynski, R. M. (2005) · Transplantation Reviews · doi:10.1016/j.trre.2005.09.001
“Similarly, using antibodies to B7-H3 (B7RP-2) [12] and B7-H4 [13], evidence has been documented for a role for these molecules in the regulation of T-cell responses.”
BackgroundMethodDendritic Cells as Keepers of Peripheral Tolerance
Ring, S., Enk, A., & Mahnke, K. (2007) · Springer eBooks · doi:10.1007/978-0-387-33785-2_4
Tran, C. (2008) · Deep Blue (University of Michigan)
Smallwood, C. A. (2012) · QSpace (Queen's University Library)
The Expression of B7-H3 Molecule in Periodontal Disease.
John, S., Kurumathur, A., Talwar, A., Kumar, K., Abraham, T., Alagiri, A., Walaja, G., & Clements, J. (2017) · PubMed Central
Astrocytes modulate microglial phenotype and dendritic cell-like properties
Padala, N. K. (2013)
O’Connor, J., Herrera, G., Jávega, B., & Martínez‐Romero, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811353-0.00058-0
Cancer Immunotherapy Treatments
Sadowsky, S. (2013) · Touro Scholar (Touro College)
MacGregor, H. L. (2020) · TSpace (University of Toronto)
Yilmaz, A., & Yu, J. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.01.446639
Huang, K., Mao, H., & Liu, C. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.08.045
RetractedHao, O.-M., Wang, X., Zhi-jun, Y., Nan, C.-H., Yu, Y., Zhang, T., Liu, Y., & Xue, Z. (2021) · Pakistan Journal of Zoology · doi:10.17582/journal.pjz/20191106011147
“Prasad reported that in mouse models of airway inflammation, B7-H3 downregulated Th1, but not Th2, responses, and B7-H3 gene knock-out mice developed severe airway diseases when compared to the wild type (Prasad et al., 2004).”
BackgroundA4GALT Mediated the Glycosylation of B7-H3 in Human Colorectal Cancer Cell LinesPreprint
Li, F., Han, D., Chen, M., Li, J., Li, Y., Wang, W., & Yu, C. (2021) · Research Square · doi:10.21203/rs.3.rs-1197553/v1
(2006) · Elsevier eBooks · doi:10.1016/b978-0-443-07271-0.50022-7
A4GALT mediated the glycosylation of B7-H3 in human colorectal cancer cell linesPreprint
Li, F., Han, D., Chen, M., Li, J., Li, Y., Wang, W., & Yu, C. (2022) · Research Square · doi:10.21203/rs.3.rs-1197553/v2
Immune checkpoint inhibitors in metastatic NSCLC: challenges and future directions (CME article)
Sridhar, A., Singh, P. K., & Parikh, K. (2023) · International Journal of Cancer Care and Delivery · doi:10.53876/001c.72631
Data from B7-H3: An Attractive Target for Antibody-based Immunotherapy
Kontos, F., Michelakos, T. P., Kurokawa, T., Sadagopan, A., Schwab, J. H., Ferrone, C. R., & Ferrone, S. (2023) · doi:10.1158/1078-0432.c.6530267
An EBNA1-YAP signaling axis drives immune escape through CD276 in EBV-associated gastric cancerPreprint
Xu, D., Huang, B., Wang, Y., Guo, J., Duan, Y., Dou, Y., Kang, W., & Wei, G. (2024) · Research Square · doi:10.21203/rs.3.rs-3283256/v1
WITHDRAWN: Next generation immune checkpoints
Perez, N. M., Moziak, K., & Martin, A. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.00009-6
Emerging CART Therapies for Pediatric Acute Myeloid Leukemia
Ceolin, V., Spadea, M., Apolito, V., Saglio, F., & Fagioli, F. (2024) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000002956
“72 Although B7-H3 was originally reported as a positive costimulator of T cells in humans, increasing evidence suggests that it may be a negative regulator.”
Li, Q., Chen, Y., Wang, M., Li, C., Ao, J., & Chen, X. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5269270
Li, Q., Chen, Y., Wang, M., Li, C., Ao, J., & Chen, X. (2025) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2025.110550
Ding, M., Zhu, G., Chen, T., Zhu, J., Mao, S., Tang, X., Wu, H., Zhen, N., Sun, F., Pan, Q., et al. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000826
“[26,27] However, the specific receptor for CD276 in humans remains unclear.”
Ding, S., Shan, Y., Sun, L., Li, S., Jiang, R., Chang, X., Huang, Z., Sun, J., Liu, C., Fang, C., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12798799
Ding, S., Shan, Y., Sun, L., Li, S., Jiang, R., Chang, X., Huang, Z., Sun, J., Liu, C., Fang, C., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12798796
Ding, S., Shan, Y., Sun, L., Li, S., Jiang, R., Chang, X., Huang, Z., Sun, J., Liu, C., Fang, C., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12798787
Ding, S., Shan, Y., Sun, L., Li, S., Jiang, R., Chang, X., Huang, Z., Sun, J., Liu, C., Fang, C., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12798790
Ding, S., Shan, Y., Sun, L., Li, S., Jiang, R., Chang, X., Huang, Z., Sun, J., Liu, C., Fang, C., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12798793
Immunotherapy approaches for the treatment of relapsed or progressive medulloblastoma
Abu-Arja, M. H., Stuckert, A. J., Ghebrelul, R. T., Chintagumpala, M., Taylor, M. D., & Ahmed, N. M. (2026) · Journal of Neuro-Oncology · doi:10.1007/s11060-026-05437-2
Advances in Lung Cancer Management: Novel Approaches and the Road Ahead
Choudhary, F., Mustafa, M., Farooqui, M. R., Nizam, A., Abdin, M. Z., & Farooqi, H. (2026) · Clinical Cancer Drugs · doi:10.2174/012212697x412648260114111222
Propriétés régulatrices des cellules dendritiques humaines traitées par l’acide mycophénolique
Lemoine, R. (2009) · theses.fr (ABES) · doi:10.70675/2a02c1e3z41ebz4e2bz96c8z03910ec1be1d
You, K., Gupta, R., Bucci, J. A., Wang, Q., & Ni, J. (2026) · Cancer Heterogeneity and Plasticity · doi:10.47248/chp2603030010
Du, P. P., Kohno, S., Wang, M., Papanicolaou, M., Vaughan-Jackson, A., Daigh, L. H., Peng, Q., Spees, K., McCormick, A. K., Diehl, M. I., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.16.752238
Tarone, L., Merighi, I. F., Tirtei, E., Giacobino, D., Morello, E. M., Cavallo, F., & Riccardo, F. (2026) · Cancers · doi:10.3390/cancers18193239
“Mechanistically, B7-H3 has been linked to reduced IL-2 production and to negative regulation of transcriptional programs involved in T-cell activation, including NFAT, AP-1, and NF-κ B [56,57].”
Paediatric therapeutic development workshop on desmoplastic small round cell tumours
Baxter, J. S., Molenaar, J. J., Agrawal, A., Amaral, A. T., Blanc, P., Bowdidge, N., Bowdidge, R., Brennan, B., Casanova, M., Moura, D. S., et al. (2026) · British Journal of Cancer · doi:10.1038/s41416-026-03631-7
Multiomics2Targets source code snapshot from GitHub
Marino, G., Clarke, D., Deng, E., Diamant, I., & Ma’ayan, A. (2024) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.13948699
ICOS and CD28: similar or separate costimulators of T cells?
van Berkel, E. A. T. (2006) · Utrecht University Repository (Utrecht University)
Metadata
- Authors
- Prasad, D. V. R., Nguyen, T., Li, Z., Yang, Y., Duong, J., Wang, Y., & Dong, C.
- Affiliations
- University of Washington (US)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-08
- Volume
- 173
- Issue
- 4
- Pages
- 2500-2506
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2110172571
- Cited by
- 368
- References
- 42
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 30 · 2023: 22 · 2022: 27 · 2021: 34 · 2020: 27 · 2019: 18 · 2018: 10 · 2017: 16 · 2016: 11 · 2015: 11 · 2014: 6 · 2013: 14 · 2012: 17
- FWCI
- 5.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- B7-H3, T cell activation, dendritic cells, professional antigen-presenting cells, IFN-gamma production, experimental autoimmune encephalomyelitis, T cell proliferation, mice
- MeSH terms
- Animals, Antigen-Presenting Cells, B-Lymphocytes, Cells, Cultured, Dendritic Cells, Encephalomyelitis, Autoimmune, Experimental, Female, Flow Cytometry, Lymphocyte Activation, Macrophages, T-Lymphocytes, Cytokines, B7-1 Antigen, Antibodies, Blocking, Mice, Rats, B7 Antigens
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
